Phreesia, Inc. reported $508M of revenue over the trailing twelve months, +13% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $508M (to Q2 2027). Net income: $10M, trailing twelve months to Q2 2027. Free cash flow: $81M, trailing twelve months to Q2 2027. Operating margin: 2.4%, trailing twelve months to Q2 2027.

PHRPhreesia, Inc.

Healthcare

$10.67-54% 1Y

$10.67

$8.0652 weeks$23.84

PHR as reported

Phreesia, Inc. reported $508M of revenue over the trailing twelve months, +13% on the year before. 10 reported series are charted on this page, each one as filed.

$508M

Revenue, trailing twelve months · to Q2 2027 · +13% against the twelve months before

Net income: $10M
Net income · −143% year on year · trailing twelve months to Q2 2027
Free cash flow: $81M
Free cash flow · +88% year on year · trailing twelve months to Q2 2027
Operating margin: 2.4%
Operating margin · trailing twelve months to Q2 2027

Details›

Every series Ryufin has for PHR, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$508M	+13%	Q2 2027
Net income	$10M	−143%	Q2 2027
EPS	$0.17	−140%	Q2 2027
Gross margin	85%	n/a	Q2 2027
Operating margin	2.4%	n/a	Q2 2027
Net margin	2.1%	n/a	Q2 2027
ROE	1.1%	n/a	Q2 2027
ROA	0.52%	n/a	Q2 2027
ROIC	−0.39%	n/a	Q2 2027
Free cash flow	$81M	+88%	Q2 2027

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.